TENOFOVIR ALAFENAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tenofovir Alafenamide, and when can generic versions of Tenofovir Alafenamide launch?
Tenofovir Alafenamide is a drug marketed by Lupin Ltd and Apotex and is included in two NDAs.
The generic ingredient in TENOFOVIR ALAFENAMIDE is tenofovir alafenamide fumarate. There are forty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tenofovir alafenamide fumarate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TENOFOVIR ALAFENAMIDE?
- What are the global sales for TENOFOVIR ALAFENAMIDE?
- What is Average Wholesale Price for TENOFOVIR ALAFENAMIDE?
Summary for TENOFOVIR ALAFENAMIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 63 |
| Clinical Trials: | 214 |
| Patent Applications: | 422 |
| DailyMed Link: | TENOFOVIR ALAFENAMIDE at DailyMed |
Recent Clinical Trials for TENOFOVIR ALAFENAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre for the AIDS Programme of Research in South Africa | Phase 1 |
| University of Pittsburgh | Phase 1 |
| Kenya Medical Research Institute | Phase 1 |
US Patents and Regulatory Information for TENOFOVIR ALAFENAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | TENOFOVIR ALAFENAMIDE | tenofovir alafenamide fumarate | TABLET;ORAL | 214226-001 | Mar 30, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Apotex | TENOFOVIR ALAFENAMIDE FUMARATE | tenofovir alafenamide fumarate | TABLET;ORAL | 213867-001 | Mar 21, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
